PHARMING GRP SP. ADRS (PHG) — Net Asset Momentum
PHARMING GRP SP. ADRS (PHG) recorded a net asset momentum of 25.4% as of December 2025, with net assets of €277.10 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See operational self-sufficiency of PHARMING GRP SP. ADRS to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
PHARMING GRP SP. ADRS Net Asset Momentum (2021–2025)
This chart tracks PHARMING GRP SP. ADRS's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is +25.4%, with net assets of €277.10 Million EUR as of December 2025. Read debt load of PHARMING GRP SP. ADRS for a breakdown of total debt and financial obligations.
Annual Net Asset History for PHARMING GRP SP. ADRS (2021–2025)
The table below shows the complete annual net asset history for PHARMING GRP SP. ADRS from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see PHARMING GRP SP. ADRS stock valuation.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €277.10 Million | €499.96 Million | €222.86 Million | ▲ +25.4% |
| 2024 | €221.06 Million | €399.99 Million | €178.92 Million | ▲ +1.0% |
| 2023 | €218.78 Million | €462.85 Million | €244.07 Million | ▲ +6.9% |
| 2022 | €204.64 Million | €425.80 Million | €221.16 Million | ▲ +6.1% |
| 2021 | €192.92 Million | €397.31 Million | €204.40 Million | — |